RUNX3 and neoplasm: In these tumors, RUNX3 was found to enhance cell proliferation, inhibit apoptosis, and confer drug resistance, indicating that RUNX3 enhances malignant properties associated with the progression of malignancy, such as tumor invasion and metastasis.